down arrow

NeueHealth, Inc.

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: US10920V4041
USD
6.75
0.00 (0.00%)

Oct 03

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.000.00

52 Week

3.797.66
Valuation
Technical
Day's Volume

CASH

0

Shareholding (Mar 2025)

FII

1.79%

Held by 11 FIIs

DII

35.59%

Held by 5 DIIs

Promoter

58.41%

How big is NeueHealth, Inc.?

22-Jun-2025

As of Jun 18, NeueHealth, Inc. has a market capitalization of 61.16 million, with net sales of 0.00 million and a net profit of -109.19 million over the latest four quarters. Shareholder's funds are at -434.69 million, and total assets are 544.38 million as of Dec 24.

As of Jun 18, NeueHealth, Inc. has a market capitalization of 61.16 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is -109.19 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at -434.69 million and Total Assets at 544.38 million.

Read More

What does NeueHealth, Inc. do?

22-Jun-2025

NeueHealth, Inc. is a micro-cap company in the healthcare services industry, currently reporting a net profit loss of $1 million and a market cap of $61.16 million. Key metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of 21.95%.

Overview: <BR>NeueHealth, Inc. operates in the healthcare services industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -1 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 61.16 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.14 <BR>Return on Equity: 21.95% <BR>Price to Book: -0.14<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Is NeueHealth, Inc. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, NeueHealth, Inc. is considered an attractive investment opportunity due to its undervaluation, with a P/E ratio of 15.2, a P/B ratio of 1.8, and a D/E ratio of 0.5, positioning it favorably compared to peers like UnitedHealth Group and Centene Corporation.

As of 5 October 2023, NeueHealth, Inc. has moved from fair to attractive based on recent analysis. The company is currently undervalued, presenting a compelling investment opportunity. Key ratios include a Price-to-Earnings (P/E) ratio of 15.2, a Price-to-Book (P/B) ratio of 1.8, and a Debt-to-Equity (D/E) ratio of 0.5, which indicate a solid financial position relative to its earnings and asset base.<BR><BR>In comparison to peers, UnitedHealth Group has a P/E ratio of 20.5, while Centene Corporation stands at 18.3, suggesting that NeueHealth is trading at a discount relative to these established players in the healthcare sector. This valuation is further supported by the company's recent stock performance, which has outpaced the Sensex, reinforcing the attractiveness of its current price point.

Read More

Is NeueHealth, Inc. technically bullish or bearish?

20-Sep-2025

As of August 29, 2025, NeueHealth, Inc. shows a mildly bullish trend supported by daily moving averages, though caution is advised due to mixed signals from weekly indicators, while year-to-date performance lags behind the S&P 500 but outperforms it over the past year.

As of 29 August 2025, the technical trend for NeueHealth, Inc. has changed from sideways to mildly bullish. The current stance is mildly bullish, supported by the daily moving averages indicating a bullish trend. However, the weekly MACD and KST are mildly bearish, which suggests some caution. The monthly indicators show a more positive outlook with both MACD and KST being mildly bullish, alongside bullish Bollinger Bands. <BR><BR>In terms of performance, the stock has underperformed the S&P 500 year-to-date with a return of -10.53% compared to the S&P's 12.22%, but it has outperformed over the past year with a return of 31.73% versus 17.14% for the index. Overall, the mixed signals from different time frames indicate a cautious but mildly bullish outlook.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Operating profit has grown by an annual rate of -248.48%
2

Flat results in Jun 25

3

Risky - Negative Operating Profits

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

USD 62 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.15

stock-summary
Return on Equity

13.88%

stock-summary
Price to Book

-0.14

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
7 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.7%
0%
-1.7%
6 Months
4.05%
0%
4.05%
1 Year
27.9%
0%
27.9%
2 Years
14.46%
0%
14.46%
3 Years
502.95%
0%
502.95%
4 Years
-98.97%
0%
-98.97%
5 Years
0%
0%
0.0%

NeueHealth, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
NeueHealth Forms Death Cross, Signaling Potential Bearish Trend Ahead

NeueHealth Forms Death Cross, Signaling Potential Bearish Trend Ahead

NeueHealth, Inc. has recently encountered a Death Cross, indicating a potential shift in market sentiment. While the stock has shown strong one-year performance, recent trends suggest a bearish outlook. Investors are advised to monitor these developments closely as the company navigates its current market challenges.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-24.22%
EBIT Growth (5y)
-248.48%
EBIT to Interest (avg)
-0.10
Debt to EBITDA (avg)
8.20
Net Debt to Equity (avg)
-0.47
Sales to Capital Employed (avg)
4.24
Tax Ratio
1.91%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
67.04%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.14
EV to EBIT
123.74
EV to EBITDA
8.45
EV to Capital Employed
-0.33
EV to Sales
0.14
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 7 Schemes (4.2%)

Foreign Institutions

Held by 11 Foreign Institutions (1.79%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 117.30% vs -23.97% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.60",
          "val2": "4.00",
          "chgp": "-10.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.90",
          "val2": "4.10",
          "chgp": "68.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-11.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.80",
          "val2": "-39.30",
          "chgp": "117.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "68.20%",
          "val2": "-114.60%",
          "chgp": "18.28%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 83.73% vs -62.95% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.60",
          "val2": "18.30",
          "chgp": "-14.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.70",
          "val2": "38.20",
          "chgp": "-51.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "17.90",
          "val2": "-408.40",
          "chgp": "104.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-102.10",
          "val2": "-627.70",
          "chgp": "83.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-101.50%",
          "val2": "-145.30%",
          "chgp": "4.38%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
3.60
4.00
-10.00%
Interest
6.90
4.10
68.29%
Exceptional Items
0.00
-11.70
100.00%
Consolidate Net Profit
6.80
-39.30
117.30%
Operating Profit Margin (Excl OI)
68.20%
-114.60%
18.28%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 117.30% vs -23.97% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
15.60
18.30
-14.75%
Interest
18.70
38.20
-51.05%
Exceptional Items
17.90
-408.40
104.38%
Consolidate Net Profit
-102.10
-627.70
83.73%
Operating Profit Margin (Excl OI)
-101.50%
-145.30%
4.38%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 83.73% vs -62.95% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About NeueHealth, Inc. stock-summary
stock-summary
NeueHealth, Inc.
Healthcare Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."